SCHEMBL3427191

SCHEMBL3427191

Nc1cc(=O)cc(-c2ccccc2)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.49
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
AR P10275 3/20 0.46
CYP3A4 P08684 3/20 0.46
HPGD P15428 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TP53 P04637 2/20 0.46
CYP19A1 P11511 2/20 0.46
CYP1B1 Q16678 2/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
CA12 O43570 1/20 0.46
TNKS O95271 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ABCB1 P08183 1/20 0.46
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344376 0.85 PRKDC (0.56) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL6964494 0.76 PRKDC (0.49) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL11085896 0.76 NQO1 (0.54) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL27149030 0.75 EGFR (0.46) PRKDCSMN1; SMN2ARCYP3A4HPGD
SCHEMBL11084153 0.74 SLC9A1 (0.47) PRKDCSMN1; SMN2CYP3A4HPGDMEN1
SCHEMBL9179291 0.73 PLA2G2A (0.49) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL1176530 0.73 ALDH1A1 (0.58) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL9204834 0.73 PRKDC (0.46) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL14449832 0.72 PRKDC (0.45) PRKDCSMN1; SMN2NPC1RAB9AAR
SCHEMBL11085347 0.72 PRKDC (0.45) PRKDCSMN1; SMN2NPC1RAB9AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1485377-B9 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2010-10-06 EP disclosed
EP-1485377-B1 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2009-12-09 EP disclosed
EP-1039804-A4 METHOD FOR TREATING FIBROPROLIFERATIVE DISORDERS BY INHIBITORS OF PROTEIN HYDROXYLATION CORNELL RES FOUNDATION INC (US) 2007-08-08 EP disclosed
US-7044945-B2 Prevention of regression in thermal ciliary muscle tendinoplasty SAND BRUCE J 2006-05-16 US disclosed
US-20040093046-A1 Prevention of regression in thermal ciliary muscle tendinoplasty SAND BRUCE J 2004-05-13 US disclosed
EP-0808103-A4 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RES FOUNDATION INC (US) 2001-10-17 EP disclosed
WO-2000074648-A2 PREVENTION OF REGRESSION IN REFRACTIVE KERATOPLASTY SUNRISE TECHNOLOGIES INTERNATIONAL, INC. (US) 2000-12-14 WO disclosed
EP-1039804-A1 METHOD FOR TREATING FIBROPROLIFERATIVE DISORDERS BY INHIBITORS OF PROTEIN HYDROXYLATION CORNELL RESEARCH FOUNDATION, INC. (US) 2000-10-04 EP disclosed
US-6080766-A ADMINISTERING TO A PATIENT AN EFFECTIVE AMOUNT OF A HYDROXYPYRROLIDONE COMPOUND TO SUPPRESS THE FORMATION OF COLLAGEN-LIKE SUBSTANCES OR BIOSYNTHESIS OF PROCOLLAGEN CORNELL RESEARCH FOUNDATION, INC. (US) 2000-06-27 US disclosed
US-6046219-A ADMINISTERING TO THE PATIENT FOR TREATING THE CONDITIONS MEDIATED BY COLLAGEN FORMATION TOGETHER WITH CELL PROLIFERATION A HYDROXYPYRIDINE DERIVATIVE CORNELL RESEARCH FOUNDATION, INC. (US) 2000-04-04 US disclosed
US-5789426-A SUPPRESSION FORMATION OF COLLAGEN CORNELL RESEARCH FOUNDATION, INC. (US) 1998-08-04 US disclosed
EP-0808103-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1997-11-26 EP disclosed
WO-1996022021-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1996-07-25 WO disclosed
EP-0489877-B1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 2-AMINO-6-PHENYL-4H-PYRAN-4-ONES UPJOHN CO (US) 1995-09-20 EP disclosed
US-5302613-A Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones THE UPJOHN COMPANY (US) 1994-04-12 US disclosed
US-5302613-A Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones THE UPJOHN COMPANY (US) 1994-04-12 US disclosed
US-5252735-A Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones THE UPJOHN COMPANY (US) 1993-10-12 US disclosed
US-5252735-A Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones THE UPJOHN COMPANY (US) 1993-10-12 US disclosed
EP-0489877-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 2-AMINO-6-PHENYL-4H-PYRAN-4-ONES. UPJOHN CO (US) 1992-06-17 EP disclosed
WO-1992000290-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 2-AMINO-6-PHENYL-4H-PYRAN-4-ONES THE UPJOHN COMPANY (US) 1992-01-09 WO disclosed